3T intraoperative MRI for management of pediatric CNS neoplasms

A F Choudhri1, P Klimo2, T S Auschwitz3

  • 1From the Departments of Radiology (A.F.C., M.T.W.) Neurosurgery (A.F.C., P.K., T.S.A., F.A.B.) Ophthalmology (A.F.C.), University of Tennessee Health Science Center, Memphis, Tennessee Le Bonheur Neuroscience Institute (A.F.C., P.K., M.T.W., F.A.B.), Le Bonheur Children's Hospital, Memphis, Tennessee achoudhri@uthsc.edu.

Abstract

Insights

Intraoperative MRI in pediatric brain tumor surgery is safe and effective, increasing gross total resection rates. This advanced imaging reduces the need for repeat surgeries and postoperative scans in children.

Area of Science:

  • Pediatric Neurosurgery
  • Neuroradiology
  • Oncology

Background:

  • High-field-strength intraoperative MRI (iMRI) is a valuable tool for brain tumor resection.
  • Its precise impact on pediatric central nervous system (CNS) tumor management requires further elucidation.

Purpose of the Study:

  • To assess the effect of 3 Tesla (3T) intraoperative MRI on the surgical management of pediatric CNS tumors.

Main Methods:

  • A retrospective analysis of 194 pediatric patients undergoing iMRI-guided surgery over 24 months.
  • Data included tumor characteristics, surgical approach, operating room time, residual tumor volume, reoperation rates, and complications.
  • Comparison was made with pre-iMRI control cases.

Main Results:

  • 93% of patients with a goal of gross total resection achieved it.
  • 21% of patients had additional tumor resected after iMRI.
  • No MR imaging-related safety issues occurred, and the 30-day reoperation rate was less than 1%.

Conclusions:

  • Intraoperative MRI is safe for pediatric brain tumor surgery.
  • It enhances the likelihood of achieving gross total resection.
  • It reduces the need for early reoperation and repeat sedation for postoperative scans, despite increased operating room time.